DENTSPLY SIRONA Stock Forecast, Price & News

DENTSPLY SIRONA's stock was trading at $42.56 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, XRAY shares have increased by 1.9% and is now trading at $43.37.
View which stocks have been most impacted by COVID-19.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for DENTSPLY SIRONA.

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for DENTSPLY SIRONA.

DENTSPLY SIRONA Inc (NASDAQ:XRAY) announced its earnings results on Thursday, August, 6th. The medical instruments supplier reported ($0.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.16. The medical instruments supplier had revenue of $490.60 million for the quarter, compared to analyst estimates of $492.55 million. DENTSPLY SIRONA had a positive return on equity of 7.13% and a negative net margin of 1.40%. DENTSPLY SIRONA's revenue was down 51.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.66 EPS.
View DENTSPLY SIRONA's earnings history.

DENTSPLY SIRONA declared a quarterly dividend on Wednesday, July 29th. Investors of record on Friday, September 25th will be given a dividend of $0.10 per share on Friday, October 9th. This represents a $0.40 dividend on an annualized basis and a yield of 0.92%. The ex-dividend date is Thursday, September 24th.
View DENTSPLY SIRONA's dividend history.

14 brokers have issued 1-year price targets for DENTSPLY SIRONA's stock. Their forecasts range from $38.00 to $66.00. On average, they expect DENTSPLY SIRONA's stock price to reach $49.29 in the next twelve months. This suggests a possible upside of 13.6% from the stock's current price.
View analysts' price targets for DENTSPLY SIRONA.

DENTSPLY SIRONA saw a decline in short interest in August. As of August 31st, there was short interest totaling 4,660,000 shares, a decline of 17.8% from the August 15th total of 5,670,000 shares. Based on an average trading volume of 1,660,000 shares, the days-to-cover ratio is currently 2.8 days. Approximately 2.1% of the shares of the company are short sold.
View DENTSPLY SIRONA's Short Interest.

Some companies that are related to DENTSPLY SIRONA include Align Technology (ALGN), West Pharmaceutical Services (WST), Cooper Companies (COO), Quidel (QDEL), Haemonetics (HAE), Neogen (NEOG), ICU Medical (ICUI), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), OraSure Technologies (OSUR), Meridian Bioscience (VIVO), Anika Therapeutics (ANIK) and Antares Pharma (ATRS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), Boeing (BA), General Electric (GE), Gilead Sciences (GILD), IBM (IBM), Broadcom (AVGO), Tesla (TSLA) and Comcast (CMCSA).

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

DENTSPLY SIRONA's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.49%), First Eagle Investment Management LLC (3.21%), Nuance Investments LLC (3.06%), Bank of Montreal Can (0.94%), Ninety One UK Ltd (0.89%) and New York State Common Retirement Fund (0.88%). Company insiders that own DENTSPLY SIRONA stock include Betsy D Holden, Daniel P Key, Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Markus Boehringer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman and William E Newell.
View institutional ownership trends for DENTSPLY SIRONA.

XRAY stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Vanguard Group Inc., FMR LLC, FMR LLC, SG Americas Securities LLC, Candriam Luxembourg S.C.A., Robeco Institutional Asset Management B.V., and State of Wisconsin Investment Board. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Michael C Alfano, and William E Newell.
View insider buying and selling activity for DENTSPLY SIRONA.

XRAY stock was acquired by a variety of institutional investors in the last quarter, including Ninety One UK Ltd, Sound Shore Management Inc CT, Nuance Investments LLC, Bank of Montreal Can, Victory Capital Management Inc., Sumitomo Mitsui Trust Holdings Inc., State of Tennessee Treasury Department, and Reinhart Partners Inc.. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Betsy D Holden, Daniel P Key, Donald M Jr Casey, and Gregory T Lucier.
View insider buying and selling activity for DENTSPLY SIRONA.

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of XRAY stock can currently be purchased for approximately $43.37.

DENTSPLY SIRONA has a market capitalization of $9.48 billion and generates $4.03 billion in revenue each year. The medical instruments supplier earns $262.90 million in net income (profit) each year or $2.45 on an earnings per share basis. DENTSPLY SIRONA employs 15,200 workers across the globe.

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at 844-546-3722 or via email at [email protected]